Latest Boardroom Shifts News

RPM Automotive's CEO Roy Norris resigned following mutual agreement with the board amid strategic leadership discussions. The company is launching a search for a new CEO and aims to bolster its governance with new independent directors.

Corporate Travel Management (ASX:CTD) has extended its exclusive contract with the UK Ministry of Defence to provide accommodation services for the Afghan Resettlement Programme, with expected transaction values reaching £28 million in the first six months.

Metallium Limited has appointed key board members and executives to strengthen governance and operational capacity as it advances its Flash Joule Heating technology towards commercialisation in the US.

Cue Energy Resources trimmed its 2P reserves by 9% to 4.5 million barrels of oil equivalent as of June 2026, driven by production and downward revisions across key assets. The company flagged a $3-$5 million non-cash impairment tied to Maari and Sampang fields amid a strategic exit from the Sampang PSC.

Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.

Coppermoly Limited's Managing Director and CEO Dickson Leah has resigned for personal reasons but will oversee a handover as the board searches for a successor. The company continues to focus on its expanding copper, gold, and critical minerals portfolio across Queensland and Western Australia.

Metcash Limited posted a steady FY26 performance, with group revenue rising to $19.6 billion and EBITDA up 1.9%, driven by growth in Food and digital channels despite challenges in Hardware.

Rimfire Pacific Mining has appointed Bronwyn Barnes as Executive Chair and secured $2.3 million in a placement to advance its scandium exploration and development strategy.

Challenger Gold has completed an A$85 million equity raise backed by key insiders and appointed a new leadership team to drive its transition from exploration to development at Hualilan and El Guayabo.

Clarity Pharmaceuticals has presented compelling clinical evidence that its investigational 64Cu-SAR-bisPSMA diagnostic and 67Cu-SAR-bisPSMA therapeutic candidates outperform current standards in prostate cancer care, positioning the company for regulatory and commercial milestones.

Integral Diagnostics has installed Jason Martinez as its new CEO, marking a leadership change as the company prepares to present its FY26 results. Martinez brings over 20 years of diagnostic imaging experience and aims to drive growth and innovation following the retirement of long-serving CEO Ian Kadish.

SciDev Ltd has landed its first contracts in the data centre sector, targeting water recycling and treatment services for two major Australian hyperscale operators. The deals are expected to generate around $0.5 million in revenue in the first half of FY27, marking a strategic step into a high-growth market.